AstraZeneca is focused on the future of oncology through clinical research. We’re investigating signaling pathways to evaluate their utility in the treatment of a multitude of tumor types. To learn more, view or download the slide presentation for the signaling pathways that may interest you:
Proliferation: MEK 1/2
View | Download
Anti-angiogenesis and Proliferation
View | Download
Endothelin A Receptors
View | Download
Anti-angiogenesis VEGF Signaling
View | Download
Inhibition of DNA Repair: PARP
View | Download
Proliferation: Aurora Kinase
View | Download
Next: Investigational Research Mechanism of Action